JP4487307B2 - Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device - Google Patents

Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device Download PDF

Info

Publication number
JP4487307B2
JP4487307B2 JP2004094261A JP2004094261A JP4487307B2 JP 4487307 B2 JP4487307 B2 JP 4487307B2 JP 2004094261 A JP2004094261 A JP 2004094261A JP 2004094261 A JP2004094261 A JP 2004094261A JP 4487307 B2 JP4487307 B2 JP 4487307B2
Authority
JP
Japan
Prior art keywords
chemical solution
chemical
bag
solution
internal cavity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2004094261A
Other languages
Japanese (ja)
Other versions
JP2005278748A (en
Inventor
琢己 菊地
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP2004094261A priority Critical patent/JP4487307B2/en
Publication of JP2005278748A publication Critical patent/JP2005278748A/en
Application granted granted Critical
Publication of JP4487307B2 publication Critical patent/JP4487307B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Description

この発明は複数薬液を分離状態で薬液バッグのそれぞれの隔室に収容しておき、点滴や透析時に隔室間の弱シール部を開通させ、薬液を混合して使用するようにした薬液バッグからの薬液排出方法及びシステム、薬液収容封止体並びに穿刺型薬液排出具に関するものである。   This invention contains a plurality of chemical solutions in respective compartments of the chemical solution bag in a separated state, opens a weak seal between the compartments during drip or dialysis, and mixes the chemical solutions for use. The chemical solution discharging method and system, the chemical solution containing sealing body, and the puncture type chemical solution discharging tool.

点滴や透析などのための医療用混合型薬液封止体として2液若しくは3液以上の多液混合型のものがある。多液混合型薬液封止体においては、軟弱フィルムを素材とする薬液バッグの内部空洞は弱シール部によってそれぞれ異なった薬液を収容する複数の隔室に分離されている。薬液バッグの外周には、プラスチック成型品としての薬液排出口が設けられ、薬液排出口は筒状に形成され、その内部空洞は一端側で一方の隔室に開口しているが、他端にはゴム栓が設けられている。患者への薬液の投与に先立って薬液バッグを外側から加圧することによって弱シール部が開通せしめられ、薬液バッグの内部空洞は一室となるため2種類の薬液は混合され、点滴用チューブに接続された輸液セットの穿刺針によりゴム栓を穿刺し、薬液バッグよりの薬液の投与が可能となる。そして、この種の医療用混合型薬液封止体においては薬液の投与に先立って弱シール部の開通を行うことにより両液を混合せしめる作業は必須であり、他方、弱シール部の開通を行わないままで薬液排出口におけるゴム栓の穿刺を行うと、薬液排出口側の隔室における薬液のみが投与されてしまうという誤操作の可能性があった。この問題点に対処する従来技術として、薬液バッグの内部空洞を二つの隔室に分離する第1の弱シール部に加えて、薬液排出口の直前に第2の弱シール部を設け、第1の弱シール部の開通に要する圧力に対して第2の第2の弱シール部を同等若しくはそれ以上とすることにより、薬液の混合後に排出が行われるようにしたものが提案されている(特許文献1参照)。
特開2004−661号公報
2. Description of the Related Art There are two or more liquid-mixed multi-liquid mixed type medical sealers for infusion or dialysis. In the multi-liquid mixed type chemical liquid sealed body, the internal cavity of the chemical liquid bag made of a soft film is separated into a plurality of compartments each containing different chemical liquids by a weak seal portion. A chemical solution discharge port as a plastic molded product is provided on the outer periphery of the chemical solution bag, the chemical solution discharge port is formed in a cylindrical shape, and its internal cavity opens to one compartment on one end side, but on the other end Is provided with a rubber stopper. Prior to administration of the drug solution to the patient, the weak seal is opened by pressurizing the drug solution bag from the outside, and the internal cavity of the drug solution bag becomes a single chamber, so the two types of drug solutions are mixed and connected to the tube for infusion The rubber plug is punctured by the puncture needle of the infusion set thus made, and the drug solution can be administered from the drug solution bag. In this type of medical mixed-type liquid medicine sealed body, the work of mixing the two liquids by opening the weak seal part prior to the administration of the chemical liquid is essential, while the weak seal part is opened. If the rubber stopper is punctured at the chemical solution outlet without being present, there is a possibility of an erroneous operation in which only the chemical solution in the compartment on the chemical solution outlet side is administered. As a conventional technique for coping with this problem, in addition to the first weak seal portion that separates the internal cavity of the chemical solution bag into two compartments, a second weak seal portion is provided immediately before the chemical solution outlet, It has been proposed that the second weak seal portion be equal to or higher than the pressure required for opening the weak seal portion so that the discharge is performed after mixing of the chemicals (patent) Reference 1).
JP 2004-661 A

特許文献1の技術は二つの隔室を分離する第1の弱シール部に加えて薬液排出口の直前に第2の弱シール部を設け、これらの弱シール部を順次開通させることで未混合のままの薬液の投与は防止しうるが、弱シール部を2個所設けているため、製造工程が複雑化し、コスト増となり、ユーザ側に2段階の加圧による開通作業を強いることになり、作業性としては必ずしも良くなかった。また、薬液バッグの加圧の仕方によっては第1の弱シール部→第2の弱シール部の順序によって必ずしも開通されるとは限らず、薬液排出口側の第2の弱シール部が先に開通されてしまうと、投与作業にそのまま移行してしまう可能性があり、この場合は未混合で1液のみ投与されてしまう結果となる。   In the technique of Patent Document 1, in addition to the first weak seal portion that separates the two compartments, a second weak seal portion is provided immediately before the chemical solution discharge port, and these weak seal portions are sequentially opened so that they are not mixed. However, since the two weak seals are provided, the manufacturing process becomes complicated and the cost increases, and the user is forced to open the work by two stages of pressurization. The workability was not always good. In addition, depending on the method of pressurizing the chemical solution bag, the first weak seal portion is not necessarily opened in the order of the second weak seal portion, and the second weak seal portion on the chemical solution outlet side is the first. If it is opened, there is a possibility of shifting to the administration work as it is. In this case, only one solution is administered without mixing.

この発明は以上の問題点に鑑みてなされてものであり、未開通の状態では投与を行い得ない2液混合型の薬液バッグの新規な構造を提供し、製造コストが低廉でありかつユーザ側の作業性が良好であるにもかかわらず、1液のみが投与されてしまうという誤操作の可能性をより確実に排除することを目的とする。   The present invention has been made in view of the above problems, and provides a novel structure of a two-component mixed-type drug solution bag that cannot be administered in an unopened state. The object is to more surely eliminate the possibility of an erroneous operation in which only one solution is administered in spite of good workability.

請求項1に記載の発明によれば、軟弱フィルム状素材にて形成された薬液バッグの内部空洞を隔壁手段により複数の隔室に区画し、それぞれの隔室に別々の薬液を封入すると共に、隔壁手段の開通により薬液の混合が行われたことを混合前から混合後の薬液の化学特性の変化により検出する検出手段と、その検出に至るまでは薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを阻止することにより薬液バッグからの薬液の排出を禁止する薬剤排出禁止手段とを準備し、薬液の混合を前記検出手段により検出後には薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを許容するべく薬剤排出禁止手段を無効とし、薬液バッグからの薬液の排出を可能とする薬液排出方法が提供される。 According to the first aspect of the present invention, the internal cavity of the chemical solution bag formed of the soft film-like material is divided into a plurality of compartments by the partition means, and separate chemical solutions are sealed in each compartment, Detection means for detecting that the chemical solution has been mixed by opening the partition means by changing the chemical characteristics of the chemical solution after mixing, and until the detection, the puncture-type chemical solution is discharged into the internal cavity of the chemical solution bag And a medicine discharge prohibiting means for prohibiting the discharge of the chemical solution from the chemical solution bag by preventing the access of the device, and after detecting the mixing of the chemical solution by the detection means , the puncture type chemical solution discharge device into the internal cavity of the chemical solution bag A chemical discharge method is provided in which the chemical discharge prohibiting means is disabled to allow access to the liquid and the chemical liquid can be discharged from the chemical bag.

請求項に記載の発明によれば、軟弱フィルム状素材にて形成され、その内部空洞を隔壁手段により複数の隔室に区画し、それぞれの隔室に別々の薬液を封入して構成される薬液バッグと、隔室の一つに近接するように設けられ、薬液バックの内部空洞を通常は閉鎖し、穿刺型薬液排出具が挿通されることにより薬液バッグ中の薬液を排出を許容する閉鎖部材とよりなり、前記閉鎖部材はそれが近接する一つの隔室に収容される薬液の化学特性に応動して、薬液の分離状態における薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを阻止する状態と、薬液の混合状態における薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを許容する状態との間において状態変化することを特徴とする薬液収納封止体が提供される。 According to invention of Claim 2 , it is formed with a soft film-like raw material, the internal cavity is divided into a plurality of compartments by the partition means, and separate chemicals are sealed in each compartment. Closed to the chemical solution bag and close to one of the compartments, the internal cavity of the chemical solution bag is normally closed, and the puncture type chemical solution discharge tool is inserted to allow the chemical solution in the chemical solution bag to be discharged. The closure member is responsive to the chemical characteristics of the chemical solution contained in one compartment adjacent to the closure member, and provides access to the puncture-type chemical solution discharge tool to the internal cavity of the chemical solution bag in the separated state of the chemical solution. There is provided a medicinal solution storage / sealing body characterized in that the state changes between a blocking state and a state in which access to the puncture-type medicinal solution discharging tool into the internal cavity of the medicinal solution bag in a mixed state of the medicinal solution is permitted.

請求項に記載の発明によれば、軟弱フィルム状素材にて形成された薬液バッグの内部空洞を隔壁手段により複数の隔室に区画し、それぞれの隔室に別々の薬液を収容すると共に閉鎖部材により閉鎖された薬液バッグからの薬液の排出のため前記閉鎖部材に穿刺される針状部を備えた穿刺型薬液排出具であって、前記穿刺型排出具における閉鎖部材に穿刺した際に薬液に接する部位に薬液の化学特性に応動して薬液通路の開閉を行なう開閉手段を設け、前記開閉手段は、薬液バッグの隔壁手段により薬液バッグ中の薬液が分離状態を維持している間は薬液通路を閉鎖し、隔壁手段が開通されることにより薬液が混合後は薬液通路を開放する穿刺型薬液排出具が提供される。

According to the third aspect of the present invention, the internal cavity of the chemical solution bag formed of the soft film-like material is divided into a plurality of compartments by the partition means, and separate chemical solutions are accommodated in the respective compartments and closed. A puncture-type drug solution discharging device having a needle-like portion that is punctured into the closure member for discharging the drug solution from a drug solution bag closed by the member, and the drug solution when puncturing the closure member in the puncture-type discharge device An opening / closing means for opening and closing the chemical liquid passage in response to the chemical characteristics of the chemical solution is provided at a site in contact with the chemical solution, and the opening / closing means is configured to keep the chemical solution in the chemical solution bag separated by the partition means of the chemical solution bag. There is provided a puncture-type drug solution discharger that closes the passage and opens the drug solution passage by opening the partition means after the solution is mixed.

この発明によれば、水素イオン濃度(pH)値などの薬液の化学特性の変化を検出することにより薬液の搬出禁止と排出許可とを切り替えているため、隔壁手段が開放されるまでは薬液の排出を確実に阻止し、未混合の薬液が誤投与される可能性を完全に排除することができる。   According to the present invention, since the chemical solution is prohibited from being carried out and permitted to be discharged by detecting a change in the chemical properties of the chemical solution such as the hydrogen ion concentration (pH) value, the chemical solution is kept until the partition means is opened. Elimination can be reliably prevented, and the possibility of misadministration of an unmixed drug solution can be completely eliminated.

図1において、薬液バッグ10は厚さ200ミクロンといったポリプロピレンフィルムなどの軟弱フィルムを素材とする。ポリプロピレンレンフィルムの外周はその軟化温度より十分高い120℃といった高温にて加圧されることにより形成された強シール部12により封止され、上面から見て矩形の袋状をなしている。強シール部12には懸垂孔13が穿設され、この懸垂孔13によって薬液バッグ10を点滴台などに吊り下げ保持し、点滴や透析作業を行うことになる。   In FIG. 1, the chemical solution bag 10 is made of a soft film such as a polypropylene film having a thickness of 200 microns. The outer periphery of the polypropylene film is sealed by a strong seal portion 12 formed by being pressed at a high temperature such as 120 ° C., which is sufficiently higher than its softening temperature, and has a rectangular bag shape when viewed from above. A suspension hole 13 is formed in the strong seal portion 12, and the drug solution bag 10 is suspended and held by the suspension hole 13 on an infusion stand or the like to perform infusion or dialysis.

薬液バッグ10の長さ方向における中間部位において全幅にわたって弱シール部14が延びており、弱シール部14によって薬液バッグ10の表裏面が接着され、薬液バッグ10の内部空洞は第1隔室16と第2隔室18とに区画される。弱シール部14がこの発明の隔室手段を構成し、隔壁手段としては弱シール部14以外にフランジジグルピンなどの隔室部材(隔壁治具)も含まれる。第1隔室16に第1薬液が充填され、第2隔室18に第2薬液が充填される。弱シール部14は薬液バッグ10を形成するポリプロピレンフィルムの表裏面をその軟化温度よりやや高い110℃といった相対的に低温にて加圧することにより形成される。そのため、第1隔室16と第2隔室18にそれぞれの薬液を収容した状態で隔室16, 18の部位において薬液バッグ10における薬液を外側より加圧することにより、強シール部12はそのままに弱シール部14を破壊・開通せしめ、第1薬液と第2薬液との混合を行うことができる。透析用の補充液の場合、第1薬液はブドウ糖を主体にし塩化カルシュームなどを含み、pH=4.0といった酸性に調整され、第2薬液は塩化ナトリウムを主体にpH=9.0といったアルカリ性に調整されている。そして、混合によりpH=7.4といった血液のpH相当値となる。しかしながら、第1薬液と第2薬液とを混合後長時間経過すると不溶性の異物を生ずることがあるため、投与直前に第1薬液と第2薬液との混合を行なうべく、直前の事前作業として弱シール部14の開通を行なってから投与が行われる。また、投与直前に弱シール部14の開通作業が必要な旨の注意書が薬液バッグ10の表面に印刷されている。しかしながら、弱シール部14の開通を怠る誤作業の恐れはあり、この場合は第2隔室18の薬液のみが投与されてしまう可能性がある。この発明の第1の実施形態は、弱シール部14の開通の有無を第1薬液と第2薬液との混合による水素イオン濃度(pH)の変化を検出し、混合があったと判断された場合にのみ透析や点滴の作業に移行が可能となるように薬液バッグ10からの薬液排出部の構成に工夫を加えたものである。   The weak seal portion 14 extends over the entire width at an intermediate portion in the length direction of the chemical solution bag 10, and the front and back surfaces of the chemical solution bag 10 are adhered by the weak seal portion 14, and the internal cavity of the chemical solution bag 10 is connected to the first compartment 16. It is partitioned into a second compartment 18. The weak seal portion 14 constitutes the compartment means of the present invention, and the partition means includes a compartment member (a partition jig) such as a flange jiggle pin in addition to the weak seal portion 14. The first compartment 16 is filled with the first chemical solution, and the second compartment 18 is filled with the second chemical solution. The weak seal portion 14 is formed by pressing the front and back surfaces of the polypropylene film forming the chemical solution bag 10 at a relatively low temperature such as 110 ° C., which is slightly higher than the softening temperature. Therefore, the strong seal portion 12 is left as it is by pressurizing the chemical solution in the chemical solution bag 10 from the outside in the compartments 16 and 18 in a state where the respective chemical solutions are accommodated in the first compartment 16 and the second compartment 18. The weak seal portion 14 can be broken and opened, and the first chemical solution and the second chemical solution can be mixed. In the case of a dialysis replenisher, the first chemical is mainly composed of glucose and contains calcium chloride, etc., and is adjusted to an acidity such as pH = 4.0, and the second chemical is mainly adjusted to an alkalinity, such as sodium chloride, and pH = 9.0. . Then, by mixing, a blood pH equivalent value of pH = 7.4 is obtained. However, if a long time elapses after mixing the first chemical solution and the second chemical solution, insoluble foreign matter may be generated, so that the first chemical solution and the second chemical solution should be mixed just before administration, so that it is weak as the previous preliminary work. Administration is performed after the seal portion 14 is opened. In addition, a cautionary note that the opening operation of the weak seal portion 14 is necessary immediately before administration is printed on the surface of the drug solution bag 10. However, there is a risk of erroneous work neglecting to open the weak seal portion 14, and in this case, only the chemical solution in the second compartment 18 may be administered. In the first embodiment of the present invention, the presence or absence of opening of the weak seal portion 14 is detected by detecting a change in the hydrogen ion concentration (pH) due to the mixing of the first chemical liquid and the second chemical liquid, and it is determined that there is mixing. In addition, a device is added to the configuration of the chemical solution discharge unit from the chemical solution bag 10 so that the dialysis and the drip operation can be shifted to the above.

薬液排出口20は一端20-1が閉鎖した筒状をなし、ポリプロピレンなどのプラスチック(薬液バッグ10との密着性を得るため薬液バッグと同一プラスチック素材とする必要がある)の成形品で構成される。薬液バッグ10の表裏面を形成するプラスチックフィルムは薬液排出口20を上下より挟みつつ加熱密着され、これにより薬液排出口20に近接した側の隔室18の封止が行われている。薬液排出口20の内部に閉鎖部材としての内蓋22(この発明の薬液排出禁止手段)が設けられる。内蓋22はそれに接触する液体の水素イオン濃度(pH)に応動する水素イオン濃度感応伸縮部材(所謂形状記憶素子)を備えており、通常は薬液排出口20の内周面に強固に密着することにより薬液バッグ10の内部空洞を外部に対して密閉し、点滴チューブから延びる輸液セットの穿刺針50(この発明の穿刺型薬液排出具)の挿入を阻止するが、弱シール部14の開通により薬液の混合が行われたことによる水素イオン濃度の変化に感応し、薬液排出口20の内周面との密着を解消し、穿刺針50の挿入を許容するように構成される。即ち、図2に示すように、内蓋22はそれに接触する液体の水素イオン濃度に感応して拡縮する円板形状の水素イオン濃度感知体24(薬液の混合が行われたことを混合前から混合後の薬液の化学特性の変化により検出する本発明の検出手段を構成する)と、水素イオン濃度感知体24を上下より挟着保持する硬質プラスチック製薄板にて形成された円板状部材26, 28とから構成される。円板状部材26, 28としては硬質プラスチック以外にも素材を問わず、場合によっては金属薄板を使用することも可能である。薬液バッグ10の内部空洞側(図2の上側)の円板状部材26は多数の液体流通孔26Aを備えたメッシュ状に構成され、液体流通孔26Aは薬液バッグ10内の薬液の自由流通に支障を及ぼさない内径(0.5〜1.0mm程度)に設定される。薬液バッグ10の外側(図2の下側)の円板状部材28は無垢の硬質プラスチック薄板であり、輸液セットの穿刺針50を挿入しても突き破られないような硬度及び肉厚のものであれば素材は問わない。硬質プラスチックを素材としても0.5〜1.0ミリメートル程度の肉厚を有していればこの目的には十分適合しうる。図2に示すように円板状部材26, 28は薬液排出口20の筒状部20-2の内径より幾分小さな内径をなしており、水素イオン濃度感知体24の対向面に接着剤などの適当な手段により強固に貼着されている。水素イオン濃度感知体24は薬液バッグ10の弱シール部14が未開通時の第2室18の薬液の水素イオン濃度値(アルカリ性)と薬液バッグ10の弱シール部14が開通後の混合の薬液の水素イオン濃度値(略中性)との間の水素イオン濃度値を閾値に拡縮を行うものである。即ち、水素イオン濃度感知体24はそれに接触する液体の水素イオン濃度値が閾値(例えばpH=8.0)より大きいアルカリ性のときは、図2(イ)に示すようにその外径が薬液排出口20の筒状部20-2の内径に密着・固着した拡径状態をとる。然るに、水素イオン濃度感知体24に接触する液体の水素イオン濃度値が閾値(例えばpH=8.0)より小さくなり中性値(pH=7.4)となると、水素イオン濃度感知体24は、図2(ロ)に示すようにその外径が薬液排出口20の筒状部20-2の内径離間した縮径状態をとる。   The chemical solution outlet 20 has a cylindrical shape with one end 20-1 closed, and is made of a molded product of plastic such as polypropylene (need to be made of the same plastic material as the chemical solution bag in order to obtain adhesion to the chemical solution bag 10). The The plastic film forming the front and back surfaces of the chemical solution bag 10 is heated and adhered while sandwiching the chemical solution discharge port 20 from above and below, thereby sealing the compartment 18 on the side close to the chemical solution discharge port 20. An inner lid 22 (chemical liquid discharge prohibiting means of the present invention) as a closing member is provided inside the chemical liquid discharge port 20. The inner lid 22 is provided with a hydrogen ion concentration sensitive elastic member (so-called shape memory element) that responds to the hydrogen ion concentration (pH) of the liquid in contact with the inner lid 22, and normally tightly adheres to the inner peripheral surface of the chemical solution outlet 20. As a result, the internal cavity of the drug solution bag 10 is sealed from the outside and insertion of the puncture needle 50 (puncture type drug solution discharger of the present invention) of the infusion set extending from the drip tube is prevented. It is configured to respond to changes in the hydrogen ion concentration due to the mixing of the chemical solution, eliminate the close contact with the inner peripheral surface of the chemical solution discharge port 20, and allow the insertion of the puncture needle 50. That is, as shown in FIG. 2, the inner lid 22 is a disk-shaped hydrogen ion concentration sensor 24 that expands / contracts in response to the hydrogen ion concentration of the liquid in contact with the inner lid 22 (before mixing the chemical solution). And a disc-like member 26 formed of a hard plastic thin plate sandwiching and holding the hydrogen ion concentration sensor 24 from above and below. , 28. The disk-shaped members 26 and 28 may be made of any material other than hard plastic, and depending on the case, a thin metal plate may be used. The disk-like member 26 on the inner cavity side (upper side in FIG. 2) of the chemical solution bag 10 is configured in a mesh shape having a large number of liquid circulation holes 26A, and the liquid circulation holes 26A allow free circulation of the chemical solution in the chemical solution bag 10. It is set to an inner diameter (about 0.5 to 1.0 mm) that does not hinder. The disk-shaped member 28 on the outer side (the lower side of FIG. 2) of the medical solution bag 10 is a solid hard plastic thin plate, and has a hardness and a thickness that does not break through even when the puncture needle 50 of the infusion set is inserted. Any material can be used. Even if a hard plastic is used as a raw material, it can sufficiently meet this purpose if it has a thickness of about 0.5 to 1.0 mm. As shown in FIG. 2, the disk-shaped members 26 and 28 have an inner diameter somewhat smaller than the inner diameter of the cylindrical portion 20-2 of the chemical solution discharge port 20, and an adhesive or the like is provided on the opposite surface of the hydrogen ion concentration sensor 24. It is firmly attached by appropriate means. The hydrogen ion concentration sensor 24 is a mixture of the chemical solution hydrogen ion concentration (alkaline) of the chemical solution in the second chamber 18 when the weak seal portion 14 of the chemical solution bag 10 is not opened and the mixed chemical solution after the weak seal portion 14 of the chemical solution bag 10 is opened. The expansion / contraction is performed using the hydrogen ion concentration value between the hydrogen ion concentration values (substantially neutral) as a threshold value. That is, when the hydrogen ion concentration sensor 24 is alkaline with a liquid hydrogen ion concentration value that is larger than a threshold value (for example, pH = 8.0), as shown in FIG. The expanded diameter state is in close contact with and fixed to the inner diameter of the cylindrical portion 20-2. However, when the hydrogen ion concentration value of the liquid in contact with the hydrogen ion concentration sensor 24 becomes smaller than a threshold value (for example, pH = 8.0) and becomes a neutral value (pH = 7.4), the hydrogen ion concentration sensor 24 is displayed as shown in FIG. As shown in (b), the outer diameter of the cylindrical portion 20-2 of the chemical solution discharge port 20 is in a reduced diameter state separated from the inner diameter.

水素イオン濃度感知体24としては水素イオン濃度値によってその体積を変化する高分子ゲルが知られており、高分子ゲルとしてはアクリルアミド共重合体両性ゲルより成るもの等がある。この種のアクリルアミド共重合体両性ゲルにおいてはpH=7.0近傍の中性状態において最小の体積を呈し、中性状態から酸側の水素イオン濃度値の溶液に浸した場合でもアルカリ側水素イオン濃度値の溶液に浸した場合のいづれの場合にあっても体積が増加する。即ち、pH=7.0近傍ではアニオンとカチオンとのイオン架橋のため収縮状態にあるが、ゲルを酸若しくはアルカリ側に移すとイオン架橋が切断され、ゲルが膨潤する(「機能性ゴム・ エラストマーの新展開」株式会社東レリサーチセンター発行69〜84ページ1997年6月発行参照)。また、特許2945966号の明細書にはアクリルアミド共重合体よりなるマイクロビーズの製造方法が開示されているが、この発明の実施形態の水素イオン濃度感知体24としてはこのようなマイクロビーズを型内で焼結し、円板形状に成形することができる。焼結構造とすることにより液体を水素イオン濃度感知体24中に速やかに浸透させ、水素イオン濃度値が中性から変化した場合の確実な体積変化を行わしめることができる。   As the hydrogen ion concentration sensor 24, a polymer gel whose volume is changed depending on the hydrogen ion concentration value is known. Examples of the polymer gel include those made of an acrylamide copolymer amphoteric gel. This type of acrylamide copolymer amphoteric gel exhibits a minimum volume in the neutral state near pH = 7.0, and even when immersed in a solution having a hydrogen ion concentration value on the acid side from the neutral state, the alkali side hydrogen ion concentration value The volume increases in any case when immersed in the solution. In other words, in the vicinity of pH = 7.0, it is in a contracted state due to ionic crosslinking between anions and cations, but when the gel is moved to the acid or alkali side, the ionic crosslinking is cut and the gel swells (“New functional rubber / elastomer Development ”, published by Toray Research Center, Inc., pages 69-84, June 1997). In addition, the specification of Japanese Patent No. 2945966 discloses a method for producing microbeads made of an acrylamide copolymer. As the hydrogen ion concentration sensor 24 of the embodiment of the present invention, such microbeads are used in the mold. And can be formed into a disk shape. By adopting the sintered structure, the liquid can be rapidly permeated into the hydrogen ion concentration sensing body 24, and a reliable volume change can be performed when the hydrogen ion concentration value changes from neutral.

弱シール部14の未開通時はアルカリ性の第2室18の薬液は硬質プラスチック円板26の液体流通孔26Aを介して水素イオン濃度感知体24に浸され、水素イオン濃度感知体24は膨張され、その外周は図2(イ)に示すように薬液排出口20の筒状部20-2の内径に密着・固着される。点滴作業のため、薬液バッグ10は懸垂孔13によって点滴台などに吊り下げ保持され、点滴チューブから延びる輸液セットの穿刺針50がゴム製の薬液排出口20のフランジ部20-1に刺入される。しかしながら、穿刺針50の先端は水素イオン濃度感知体24の下面の硬質プラスチック円板28に当たり、それを突き破ることができなく、また水素イオン濃度感知体24が薬液排出口20に固着され(薬液排出口20に対する水素イオン濃度感知体24の固着は薬液排出口20が筒状部20-2の内周の突起部20-3に係合することにより確実化され)、内蓋22を押し開けることができない。   When the weak seal portion 14 is not opened, the alkaline chemical solution in the second chamber 18 is immersed in the hydrogen ion concentration sensor 24 through the liquid flow hole 26A of the hard plastic disk 26, and the hydrogen ion concentration sensor 24 is expanded. As shown in FIG. 2 (a), the outer periphery is closely attached and fixed to the inner diameter of the cylindrical portion 20-2 of the chemical solution discharge port 20. For the drip operation, the medicinal solution bag 10 is suspended and held on an instillation stand or the like by the suspension hole 13, and a puncture needle 50 of an infusion set extending from the drip tube is inserted into the flange portion 20-1 of the rubber medicinal solution discharge port 20. The However, the tip of the puncture needle 50 hits the hard plastic disk 28 on the lower surface of the hydrogen ion concentration sensing body 24 and cannot break through it, and the hydrogen ion concentration sensing body 24 is fixed to the chemical solution outlet 20 (chemical solution discharge). The fixing of the hydrogen ion concentration sensing body 24 to the outlet 20 is ensured by engaging the chemical solution outlet 20 with the protrusion 20-3 on the inner periphery of the cylindrical portion 20-2), and pushing the inner lid 22 open. I can't.

弱シール部14の開通時は混合された中性の薬液が硬質プラスチック円板26の液体流通孔26Aを介して水素イオン濃度感知体24に浸され、水素イオン濃度感知体24は図2(ロ)に示すように収縮され、その外周は薬液排出口20の筒状部20-2の内径から離間される。したがって、フランジ部20-1に刺入される穿刺針50の先端に係合することにより内蓋22は矢印aのように押し上げられ、薬液バッグ10中に押し出される。そのため、薬液バッグ10内の混合薬液を輸液セットより排出することができる。   When the weak seal 14 is opened, the mixed neutral chemical is immersed in the hydrogen ion concentration sensor 24 through the liquid flow hole 26A of the hard plastic disk 26, and the hydrogen ion concentration sensor 24 is shown in FIG. ) And the outer periphery thereof is separated from the inner diameter of the cylindrical portion 20-2 of the chemical solution discharge port 20. Therefore, by engaging the tip of the puncture needle 50 inserted into the flange portion 20-1, the inner lid 22 is pushed up as indicated by the arrow a and pushed out into the drug solution bag 10. Therefore, the mixed chemical solution in the chemical solution bag 10 can be discharged from the infusion set.

図3は第2の実施形態の内蓋122を示しており、図2と同様に、内蓋122はそれに接触する液体のpHに感応する水素イオン濃度感知体124と、水素イオン濃度感知体124を上下より挟着保持する硬質プラスチック薄板にて形成された円板状部材126, 128とから構成される。円板状部材126, 128はその中心に開口126A, 128Aを備える。水素イオン濃度感知体124はそれに接触する薬液の水素イオン濃度値に応じて中心が閉鎖した図3(イ)の状態と中心に開口124Aを形成した図3(ロ)の状態とを切り替わるものである。水素イオン濃度感知体124の素材としては第1実施形態に準じたものである。この実施形態では、穿刺針50はフランジ部(図1のフランジ部20-1に相当する)に最も深く刺入されてもその先端は水素イオン濃度感知体124に届かないようにされている。   FIG. 3 shows an inner lid 122 of the second embodiment. As in FIG. 2, the inner lid 122 has a hydrogen ion concentration sensor 124 that is sensitive to the pH of the liquid that contacts the inner lid 122 and a hydrogen ion concentration sensor 124. Are formed of disk-like members 126 and 128 formed of a hard plastic thin plate that is sandwiched and held from above and below. The disk-shaped members 126 and 128 are provided with openings 126A and 128A at the centers thereof. The hydrogen ion concentration sensor 124 switches between the state shown in FIG. 3 (a) where the center is closed and the state shown in FIG. 3 (b) where an opening 124A is formed in the center according to the hydrogen ion concentration value of the chemical solution in contact therewith. is there. The material of the hydrogen ion concentration sensor 124 is the same as that of the first embodiment. In this embodiment, the tip of the puncture needle 50 is prevented from reaching the hydrogen ion concentration sensor 124 even if it is inserted deepest into the flange portion (corresponding to the flange portion 20-1 in FIG. 1).

図3に示す第2の実施形態の動作を説明すると、弱シール部14の未開通時はアルカリ性の第2室18の薬液により、水素イオン濃度感知体124は中心が完全閉鎖した(イ)の状態をとる。そのため、薬液バッグ10の内部空洞を閉鎖され、薬液排出口20のフランジ部20-1に輸液セットの穿刺針50を刺入しても薬液の排出は行いえない。これに対して、弱シール部14の開通時は水素イオン濃度感知体124は図3(ロ)に示すように中心に開口部124Aを形成するため薬液バッグ10の内部空洞は開放される。そのため、薬液バッグ10内の混合薬液を輸液セットより排出することができる。   The operation of the second embodiment shown in FIG. 3 will be described. When the weak seal portion 14 is not opened, the center of the hydrogen ion concentration sensor 124 is completely closed by the alkaline chemical solution in the second chamber 18 (a). Take a state. Therefore, even if the internal cavity of the drug solution bag 10 is closed and the puncture needle 50 of the infusion set is inserted into the flange portion 20-1 of the drug solution discharge port 20, the drug solution cannot be discharged. In contrast, when the weak seal portion 14 is opened, the hydrogen ion concentration sensor 124 forms an opening 124A at the center as shown in FIG. Therefore, the mixed chemical solution in the chemical solution bag 10 can be discharged from the infusion set.

図4は第3の実施形態を示しており、この第3の実施形態においては薬液排出口220自体が 水素イオン濃度感知拡縮素材にて形成される(薬液排出口220は本発明における検出手段であると共に薬液排出禁止手段でもある)。即ち、薬液排出口220は薬液バッグの内部空洞に向けて延びた先端部220-1を備えており、薬液排出口220の先端部220-1はそれに接触する薬液の水素イオン濃度値に応じてその長さが伸びた図4(イ)の状態とその長さが収縮した図4(ロ)の状態とを切り替わるものである。   FIG. 4 shows a third embodiment. In this third embodiment, the chemical solution outlet 220 itself is formed of a hydrogen ion concentration sensing expansion / contraction material (the chemical solution outlet 220 is a detection means in the present invention. It is also a means to prohibit chemical discharge). That is, the chemical solution discharge port 220 includes a tip 220-1 extending toward the internal cavity of the chemical solution bag, and the tip 220-1 of the chemical solution discharge port 220 corresponds to the hydrogen ion concentration value of the chemical solution in contact therewith. It switches between the state shown in FIG. 4 (a) where the length is extended and the state shown in FIG. 4 (b) where the length is contracted.

図4に示す第3の実施形態の動作を説明すると、弱シール部14の未開通時はアルカリ性の第2室18の薬液により、薬液排出口220は先端部220-1が伸張した(イ)の状態をとる。この伸張状態では輸液セットの穿刺針50を薬液排出口220に最も深く刺入しても、その先端が薬液バッグの内部空洞に突出することができず、薬液の排出は行いえない。これに対して、弱シール部14の開通時は薬液排出口220は先端部が220-1Aに示すように収縮した(ロ)の状態をとる。この収縮状態では輸液セットの穿刺針50を薬液排出口220に刺入することにより、その先端を薬液バッグの内部空洞に突出させ、薬液の排出を行うことができる。   The operation of the third embodiment shown in FIG. 4 will be described. When the weak seal portion 14 is not opened, the distal end portion 220-1 of the chemical solution discharge port 220 is expanded by the alkaline chemical solution in the second chamber 18 (A). Take the state. In this extended state, even if the puncture needle 50 of the infusion set is inserted deepest into the chemical solution outlet 220, the tip cannot protrude into the internal cavity of the chemical solution bag, and the chemical solution cannot be discharged. On the other hand, when the weak seal portion 14 is opened, the chemical solution discharge port 220 is in a contracted (b) state as shown in 220-1A. In this contracted state, by inserting the puncture needle 50 of the infusion set into the chemical solution discharge port 220, the tip can be protruded into the internal cavity of the chemical solution bag, and the chemical solution can be discharged.

図5は第4の実施形態を示し、この実施形態においては第3の実施形態と同様に薬液排出口320自体が水素イオン濃度感知拡縮素材にて形成されるが、水素イオン濃度値に応じて硬軟変化するのが特徴である。即ち、弱シール部14の未開通時はアルカリ性の第2室18の薬液により、薬液排出口320は硬化(密実構造化)し、この硬化状態では図5(イ)に示すように輸液セットの穿刺針50を薬液排出口320に刺入しようとしても、刺入することができず、薬液の排出は行いえない。これに対して、弱シール部14の開通時は中性の薬液が薬液排出口320に接触することにより薬液排出口320は軟化(網目構造化)し、この軟化状態では図5(ロ)に示すように輸液セットの穿刺針50を薬液排出口320に刺入するができ、薬液の排出を行うことができる。   FIG. 5 shows a fourth embodiment. In this embodiment, the chemical solution outlet 320 itself is formed of a hydrogen ion concentration sensing expansion / contraction material as in the third embodiment, but depending on the hydrogen ion concentration value. It is characterized by hard and soft changes. That is, when the weak seal portion 14 is not opened, the chemical solution discharge port 320 is cured (solid structure) by the alkaline chemical solution in the second chamber 18, and in this cured state, as shown in FIG. Even if the puncture needle 50 is to be inserted into the drug solution outlet 320, it cannot be inserted and the drug solution cannot be discharged. On the other hand, when the weak seal portion 14 is opened, the neutral chemical liquid comes into contact with the chemical liquid discharge port 320, so that the chemical liquid discharge port 320 is softened (network structure). In this softened state, FIG. As shown, the puncture needle 50 of the infusion set can be inserted into the drug solution outlet 320, and the drug solution can be discharged.

図6は第5の実施形態を示し、この実施形態においては輸液セットの穿刺針450(この発明の穿刺型薬液排出具)に水素イオン濃度感知開閉部450-1(本発明における検出手段であると共に薬液排出禁止手段でもある)を設けている。即ち、この水素イオン濃度感知開閉部450-1は水素イオン濃度感知拡縮素材にて形成され、それに接触する液体がアルカリ性の状態においては穿刺針450は図6(イ)に示すように水素イオン濃度感知開閉部450-1の内径=0となるように収縮し、薬液バッグからの薬液の排出は行いえない。これに対して、弱シール部14の開通時は中性の薬液がpH感知開閉部450-1に作用することにより水素イオン濃度感知開閉部は図6(ロ)の450-1Aに示すように全開となり、薬液バッグからの薬液の排出を行うことができる。   FIG. 6 shows a fifth embodiment. In this embodiment, the puncture needle 450 of the infusion set (the puncture-type drug solution discharge device of the present invention) and the hydrogen ion concentration sensing opening / closing section 450-1 (the detection means in the present invention). It is also a chemical discharge prohibition means. That is, the hydrogen ion concentration sensing opening / closing part 450-1 is formed of a hydrogen ion concentration sensing expansion / contraction material, and the puncture needle 450 has a hydrogen ion concentration as shown in FIG. The inner diameter of the sensing opening / closing part 450-1 contracts to 0, and the chemical solution cannot be discharged from the chemical solution bag. On the other hand, when the weak seal part 14 is opened, the neutral chemical solution acts on the pH sensing opening / closing part 450-1, so that the hydrogen ion concentration sensing opening / closing part is indicated by 450-1A in FIG. It becomes fully open, and the chemical solution can be discharged from the chemical solution bag.

以上の実施形態においては薬液バッグの弱シール部の開閉を薬液の水素イオン濃度(pH)を感知することにより行っているが、水素イオン濃度の代わりに薬液中の形状記憶素材に接触する薬液中には含まれるが混合後の薬液には含まれない特定のイオン(例えば第2室18に存在するが混合薬液には存在しないナトリウムイオン)の検知によって弱シール部の開閉を検知してもよい。また、薬液の混合状態と未混合状態とで温度が変化するものでは温度によって形態が変化する素材を使用することもできる。   In the above embodiment, the weak seal part of the chemical solution bag is opened and closed by sensing the hydrogen ion concentration (pH) of the chemical solution, but in the chemical solution that contacts the shape memory material in the chemical solution instead of the hydrogen ion concentration The opening and closing of the weak seal portion may be detected by detecting specific ions that are included in the liquid but are not included in the mixed chemical (for example, sodium ions that are present in the second chamber 18 but are not present in the mixed chemical). . Moreover, in the case where the temperature changes between the mixed state and the unmixed state of the chemical solution, a material whose form changes depending on the temperature can be used.

また、以上の実施形態においては薬液バッグの懸架状態において下側(輸液セットの穿刺針50の側)に位置する第2室18でのアルカリ性の薬液を検知することにより弱シール開通の有無を判断しているが、酸性の第1室16を輸液セットの穿刺針50の側(下側)とし、酸性と中性とで形態を変化させることで、弱シール部開通の有無を判断させるようにしてもよい。   In the above embodiment, the presence or absence of weak seal opening is determined by detecting the alkaline chemical in the second chamber 18 located on the lower side (the puncture needle 50 side of the infusion set) in the suspended state of the chemical bag. However, the acidic first chamber 16 is set to the side (lower side) of the puncture needle 50 of the infusion set, and the presence or absence of the weak seal portion is determined by changing the form between acidic and neutral. May be.

図1はこの発明の医療用混合型薬液封止体(未開通状態)の平面図である。FIG. 1 is a plan view of the medical mixed-type drug solution sealed body (unopened state) of the present invention. 図2はこの発明の第1実施形態における薬液排出口の概略的断面図であり、(イ)は閉鎖時、(ロ)は排出時を示す。2A and 2B are schematic cross-sectional views of the chemical solution outlet according to the first embodiment of the present invention. FIG. 2A shows a closed state and FIG. 2B shows a discharged state. 図3はこの発明の第2実施形態における薬液排出口の概略的断面図であり、(イ)は閉鎖時、(ロ)は排出時を示す。FIGS. 3A and 3B are schematic cross-sectional views of the chemical solution outlet according to the second embodiment of the present invention. FIG. 3A shows a closed state and FIG. 3B shows a discharged state. 図4はこの発明の第3実施形態における薬液排出口の概略的断面図であり、(イ)は閉鎖時、(ロ)は排出時を示す。FIG. 4 is a schematic cross-sectional view of a chemical solution discharge port according to a third embodiment of the present invention, where (A) shows a closed state and (B) shows a discharged state. 図5はこの発明の第4実施形態における薬液排出口の概略的断面図であり、(イ)は閉鎖時、(ロ)は排出時を示す。FIG. 5 is a schematic cross-sectional view of a chemical solution discharge port according to the fourth embodiment of the present invention, where (A) shows a closed state and (B) shows a discharged state. 図6はこの発明の第5実施形態における薬液排出口の概略的断面図であり、(イ)は閉鎖時、(ロ)は排出時を示す。FIG. 6 is a schematic cross-sectional view of a chemical solution discharge port according to a fifth embodiment of the present invention, where (A) shows a closed state and (B) shows a discharged state.

符号の説明Explanation of symbols

10…薬液バッグ
12…強シール部
13…懸垂孔
14…弱シール部
16…第1隔室
18…第2隔室
20, 120, 220, 320…薬液排出口
22…内蓋
24…水素イオン濃度(pH)感知体
26, 28…円板状部材
50, 450…穿刺針






DESCRIPTION OF SYMBOLS 10 ... Chemical solution bag 12 ... Strong seal part 13 ... Suspension hole 14 ... Weak seal part 16 ... 1st compartment 18 ... 2nd compartment
20, 120, 220, 320 ... Chemical solution outlet 22 ... Inner lid 24 ... Hydrogen ion concentration (pH) sensor
26, 28 ... disk-shaped members
50, 450 ... puncture needle






Claims (3)

軟弱フィルム状素材にて形成された薬液バッグの内部空洞を隔壁手段により複数の隔室に区画し、それぞれの隔室に別々の薬液を封入すると共に、隔壁手段の開通により薬液の混合が行われたことを混合前から混合後の薬液の化学特性の変化により検出する検出手段と、その検出に至るまでは薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを阻止することにより薬液バッグからの薬液の排出を禁止する薬剤排出禁止手段とを準備し、薬液の混合を前記検出手段により検出後には薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを許容するべく薬剤排出禁止手段を無効とし、薬液バッグからの薬液の排出を可能とする薬液排出方法。 The internal cavity of the chemical bag formed of a soft film material is divided into a plurality of compartments by partition means, and separate chemical solutions are sealed in each compartment, and the chemical solutions are mixed by opening the partition means. Detection means for detecting the change in the chemical characteristics of the chemical solution before and after mixing, and until the detection, the access from the puncture-type chemical solution discharge tool to the internal cavity of the chemical solution bag is prevented. And a medicine discharge prohibiting means for prohibiting the discharge of the chemical liquid, and after the detection of the mixing of the chemical liquid by the detecting means, the chemical discharge prohibiting means is provided to allow access of the puncture-type chemical liquid discharging tool to the internal cavity of the chemical liquid bag. A chemical solution discharge method that disables the chemical solution from the chemical solution bag. 軟弱フィルム状素材にて形成され、その内部空洞を隔壁手段により複数の隔室に区画し、それぞれの隔室に別々の薬液を封入して構成される薬液バッグと、隔室の一つに近接するように設けられ、薬液バックの内部空洞を通常は閉鎖し、穿刺型薬液排出具が挿通されることにより薬液バッグ中の薬液を排出を許容する閉鎖部材とよりなり、前記閉鎖部材はそれが近接する一つの隔室に収容される薬液の化学特性に応動して、薬液の分離状態における薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを阻止する状態と、薬液の混合状態における薬液バッグの内部空洞への穿刺型薬液排出具のアクセスを許容する状態との間において状態変化することを特徴とする薬液収納封止体。   It is made of a soft film material, and its internal cavity is divided into a plurality of compartments by partition means, and a chemical solution bag configured by enclosing a separate chemical solution in each compartment, and close to one of the compartments A closing member that normally closes the internal cavity of the drug solution bag and allows the drug solution in the drug solution bag to be discharged by insertion of the puncture-type drug solution discharge tool. In response to the chemical characteristics of the chemical solution contained in one adjacent compartment, the state in which the access to the puncture-type chemical solution discharge tool to the internal cavity of the chemical solution bag in the separated state of the chemical solution is blocked, and the chemical solution in the mixed state of the chemical solution A medicinal solution storage sealing body characterized in that the state changes between a state allowing access of a puncture type medicinal solution discharging tool to an internal cavity of a bag. 軟弱フィルム状素材にて形成された薬液バッグの内部空洞を隔壁手段により複数の隔室に区画し、それぞれの隔室に別々の薬液を収容すると共に閉鎖部材により閉鎖された薬液バッグからの薬液の排出のため前記閉鎖部材に穿刺される針状部を備えた穿刺型薬液排出具であって、前記排出具における閉鎖部材に穿刺した際に薬液に接する部位に薬液の化学特性に応動して薬液通路の開閉を行なう開閉手段を設け、前記開閉手段は、薬液バッグの隔壁手段により薬液バッグ中の薬液が分離状態を維持している間は薬液通路を閉鎖し、隔壁手段が開通されることにより薬液が混合後は薬液通路を開放する穿刺型薬液排出具。 The internal cavity of the chemical solution bag formed of a soft film-like material is partitioned into a plurality of compartments by partition means, and separate chemical solutions are accommodated in the respective compartments and the chemical solution from the chemical solution bag closed by the closing member is contained. A puncture type liquid medicine discharge device having a needle-like portion pierced into the closing member for discharge, wherein the liquid medicine reacts with a chemical property of the liquid medicine at a portion that comes into contact with the liquid medicine when puncturing the closing member in the discharge device An opening / closing means for opening and closing the passage is provided, and the opening / closing means closes the chemical liquid passage while the chemical liquid in the chemical liquid bag is maintained in a separated state by the partition means of the chemical liquid bag, and the partition means is opened. A puncture-type drug solution discharger that opens the drug channel after the drug solution is mixed.
JP2004094261A 2004-03-29 2004-03-29 Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device Expired - Fee Related JP4487307B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004094261A JP4487307B2 (en) 2004-03-29 2004-03-29 Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004094261A JP4487307B2 (en) 2004-03-29 2004-03-29 Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device

Publications (2)

Publication Number Publication Date
JP2005278748A JP2005278748A (en) 2005-10-13
JP4487307B2 true JP4487307B2 (en) 2010-06-23

Family

ID=35177786

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004094261A Expired - Fee Related JP4487307B2 (en) 2004-03-29 2004-03-29 Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device

Country Status (1)

Country Link
JP (1) JP4487307B2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4694307B2 (en) * 2005-08-17 2011-06-08 テルモ株式会社 Medical container
DE102006001610B4 (en) * 2006-01-11 2009-06-10 Sartorius Stedim Biotech Gmbh Device for attaching a sensor to containers
JP5078370B2 (en) * 2007-01-19 2012-11-21 テルモ株式会社 Medical container
JP5078385B2 (en) * 2007-02-21 2012-11-21 テルモ株式会社 Medical container
JP5781336B2 (en) * 2011-03-04 2015-09-24 テルモ株式会社 Medical multi-chamber container

Also Published As

Publication number Publication date
JP2005278748A (en) 2005-10-13

Similar Documents

Publication Publication Date Title
EP0159342B1 (en) Multiple chamber container having leak detection compartment
JP4936081B2 (en) Communication member and medical container using the same
BRPI0415438B8 (en) connector for packages containing medical liquid
JP4487307B2 (en) Chemical solution discharging method, chemical solution containing sealing body, and puncture type chemical solution discharging device
JP2000116791A (en) Indwelling canula assembly and valve plug
US6821785B1 (en) Vacuum sample collecting tube and method of collecting sample under vacuum
JP4854940B2 (en) Medical multi-chamber container
JP4299553B2 (en) Medical container
JP2001187110A (en) Cap and drug container using the same
WO2013038887A1 (en) Liquid injection device
JP2002331032A (en) Backflow prevention tool and manufacturing method thereof and medical tool using the same
TW542731B (en) Mouth member for mixed filling processing and infusion container using the mouth member
KR100816974B1 (en) Chemical liquid injection port, and chemical liquid container having the same
JP2004129867A (en) Mouth member and liquid medicine receptacle equipped therewith
JP6789157B2 (en) Medical container
JP2006212084A (en) Connector
JP2008061669A (en) Multi-chamber container
JP2003033423A (en) Elastic sealing body and pharmaceutical container using it
JP2004275472A (en) Medical valve
EP3787512B1 (en) Cap with venting plug for biological fluid collection device
JP2000262589A (en) Double chamber container
JP4821971B2 (en) Drug storage sealing body and adhesive seal
JP2001187112A (en) Liquid container with unsealing adapter
EP2641581A1 (en) Pharmaceutical agent storage container
JPH0232900B2 (en)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070319

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091204

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100308

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100321

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130409

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140409

Year of fee payment: 4

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees